HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabisulphite-induced occupational asthma in a radiographer.

Abstract
There is epidemiological evidence for an increased prevalence of occupational asthma among radiographers. However, the causes of darkroom disease are not yet defined. A 37-year-old female radiographer reported work-related asthma approximately 2 yrs after starting work in a local hospital. She was atopic and showed bronchial hyperresponsiveness to methacholine. Occupational-type exposure with a fixing agent, but not with a developer, produced an immediate-type asthmatic reaction. As the fixing agent contained sodium metabisulphite (SMBS), a substance known to cause asthma, bronchial challenges with SMBS were performed in the patient and nine asthmatic controls. The patient showed a positive bronchial immediate reaction on 2 separate days after inhalation of 48 and 96 microg SMBS, and one control also showed a significant fall in forced expiratory volume in one second after inhalation of 12 microg SMBS. The positive reaction in the control subject argues for a greater susceptibility of both persons to SMBS or its reaction product sulphur dioxide, rather than for a new occupational allergen. It is concluded that sodium metabisulphite exposure should be recognised as a cause of darkroom asthma.
AuthorsR Merget, M Korn
JournalThe European respiratory journal (Eur Respir J) Vol. 25 Issue 2 Pg. 386-8 (Feb 2005) ISSN: 0903-1936 [Print] England
PMID15684307 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Sulfites
  • sodium metabisulfite
Topics
  • Asthma (chemically induced, diagnosis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Occupational Diseases (diagnosis)
  • Occupational Exposure (adverse effects)
  • Radiology
  • Respiratory Function Tests
  • Skin Tests
  • Sulfites (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: